Ionis Pharmaceuticals, Inc.
56.02USD
-0.6900 (-1.22%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 268 | 246 | 203 | 157 | 452 | 132 | 227 | 134 |
| Cost of Revenue | 3 | 3 | 8 | 2 | 4 | 1 | 4 | 1 |
| Gross Profit | 265 | 243 | 195 | 154 | 448 | 130 | 223 | 133 |
| Operating Income | -102 | -117 | -214 | -160 | 140 | -147 | -111 | -149 |
| Net Income | -115 | -93 | -229 | -129 | 124 | -147 | -104 | -140 |
| EPS (Diluted) | $-0.69 | $-0.56 | $-1.41 | $-0.80 | $0.70 | $-0.93 | $-0.66 | $-0.95 |
Source: SEC filings (EDGAR)